144 related articles for article (PubMed ID: 26229531)
1. Consequence of Menin Deficiency in Mouse Adipocytes Derived by In Vitro Differentiation.
Parekh VI; Modali SD; Desai SS; Agarwal SK
Int J Endocrinol; 2015; 2015():149826. PubMed ID: 26229531
[TBL] [Abstract][Full Text] [Related]
2. Genome-wide characterization of menin-dependent H3K4me3 reveals a specific role for menin in the regulation of genes implicated in MEN1-like tumors.
Agarwal SK; Jothi R
PLoS One; 2012; 7(5):e37952. PubMed ID: 22666422
[TBL] [Abstract][Full Text] [Related]
3. Mouse embryo fibroblasts lacking the tumor suppressor menin show altered expression of extracellular matrix protein genes.
Ji Y; Prasad NB; Novotny EA; Kaur S; Elkahloun A; Chen Y; Zhang RZ; Chu ML; Agarwal SK; Marx SJ; Collins FS; Chandrasekharappa SC
Mol Cancer Res; 2007 Oct; 5(10):1041-51. PubMed ID: 17951404
[TBL] [Abstract][Full Text] [Related]
4. Genetic ablation of the tumor suppressor menin causes lethality at mid-gestation with defects in multiple organs.
Bertolino P; Radovanovic I; Casse H; Aguzzi A; Wang ZQ; Zhang CX
Mech Dev; 2003 May; 120(5):549-60. PubMed ID: 12782272
[TBL] [Abstract][Full Text] [Related]
5. Reconstituted expression of menin in Men1-deficient mouse Leydig tumour cells induces cell cycle arrest and apoptosis.
Hussein N; Casse H; Fontanière S; Morera AM; Asensio MJ; Bakeli S; Lu JL; Coste I; Di Clemente N; Bertolino P; Zhang CX
Eur J Cancer; 2007 Jan; 43(2):402-14. PubMed ID: 17184987
[TBL] [Abstract][Full Text] [Related]
6. Mutation of tumor suppressor gene Men1 acutely enhances proliferation of pancreatic islet cells.
Schnepp RW; Chen YX; Wang H; Cash T; Silva A; Diehl JA; Brown E; Hua X
Cancer Res; 2006 Jun; 66(11):5707-15. PubMed ID: 16740708
[TBL] [Abstract][Full Text] [Related]
7. MEN1 mutations and potentially MEN1-targeting miRNAs are responsible for menin deficiency in sporadic and MEN1 syndrome-associated primary hyperparathyroidism.
Grolmusz VK; Borka K; Kövesdi A; Németh K; Balogh K; Dékány C; Kiss A; Szentpéteri A; Sármán B; Somogyi A; Csajbók É; Valkusz Z; Tóth M; Igaz P; Rácz K; Patócs A
Virchows Arch; 2017 Sep; 471(3):401-411. PubMed ID: 28597079
[TBL] [Abstract][Full Text] [Related]
8. Epigenetic regulation of the lncRNA MEG3 and its target c-MET in pancreatic neuroendocrine tumors.
Modali SD; Parekh VI; Kebebew E; Agarwal SK
Mol Endocrinol; 2015 Feb; 29(2):224-37. PubMed ID: 25565142
[TBL] [Abstract][Full Text] [Related]
9. Differential expression of menin in various adrenal tumors. The role of menin in adrenal tumors.
Bhuiyan MM; Sato M; Murao K; Imachi H; Namihira H; Ishida T; Takahara J; Miyauchi A
Cancer; 2001 Sep; 92(6):1393-401. PubMed ID: 11745215
[TBL] [Abstract][Full Text] [Related]
10. Menin molecular interactions: insights into normal functions and tumorigenesis.
Agarwal SK; Kennedy PA; Scacheri PC; Novotny EA; Hickman AB; Cerrato A; Rice TS; Moore JB; Rao S; Ji Y; Mateo C; Libutti SK; Oliver B; Chandrasekharappa SC; Burns AL; Collins FS; Spiegel AM; Marx SJ
Horm Metab Res; 2005 Jun; 37(6):369-74. PubMed ID: 16001329
[TBL] [Abstract][Full Text] [Related]
11. Ribozyme-mediated compensatory induction of menin-oncosuppressor function in primary fibroblasts from MEN1 patients.
Luzi E; Marini F; Tognarini I; Carbonell Sala S; Galli G; Falchetti A; Brandi ML
Cancer Gene Ther; 2010 Nov; 17(11):814-25. PubMed ID: 20706287
[TBL] [Abstract][Full Text] [Related]
12. Menin missense mutants encoded by the MEN1 gene that are targeted to the proteasome: restoration of expression and activity by CHIP siRNA.
Canaff L; Vanbellinghen JF; Kanazawa I; Kwak H; Garfield N; Vautour L; Hendy GN
J Clin Endocrinol Metab; 2012 Feb; 97(2):E282-91. PubMed ID: 22090276
[TBL] [Abstract][Full Text] [Related]
13. The tumor suppressor menin regulates hematopoiesis and myeloid transformation by influencing Hox gene expression.
Chen YX; Yan J; Keeshan K; Tubbs AT; Wang H; Silva A; Brown EJ; Hess JL; Pear WS; Hua X
Proc Natl Acad Sci U S A; 2006 Jan; 103(4):1018-23. PubMed ID: 16415155
[TBL] [Abstract][Full Text] [Related]
14. Tumor suppressor menin regulates expression of insulin-like growth factor binding protein 2.
La P; Schnepp RW; D Petersen C; C Silva A; Hua X
Endocrinology; 2004 Jul; 145(7):3443-50. PubMed ID: 15044367
[TBL] [Abstract][Full Text] [Related]
15. Menin expression is regulated by transforming growth factor beta signaling in leukemia cells.
Zhang H; Liu ZG; Hua XX
Chin Med J (Engl); 2011 May; 124(10):1556-62. PubMed ID: 21740816
[TBL] [Abstract][Full Text] [Related]
16. Functional interaction between tumor suppressor menin and activator of S-phase kinase.
Schnepp RW; Hou Z; Wang H; Petersen C; Silva A; Masai H; Hua X
Cancer Res; 2004 Sep; 64(18):6791-6. PubMed ID: 15374998
[TBL] [Abstract][Full Text] [Related]
17. Twenty years of menin: emerging opportunities for restoration of transcriptional regulation in MEN1.
Dreijerink KMA; Timmers HTM; Brown M
Endocr Relat Cancer; 2017 Oct; 24(10):T135-T145. PubMed ID: 28811299
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms of disease: multiple endocrine neoplasia type 1-relation to chromatin modifications and transcription regulation.
Dreijerink KM; Höppener JW; Timmers HM; Lips CJ
Nat Clin Pract Endocrinol Metab; 2006 Oct; 2(10):562-70. PubMed ID: 17024155
[TBL] [Abstract][Full Text] [Related]
19. Menin associates with FANCD2, a protein involved in repair of DNA damage.
Jin S; Mao H; Schnepp RW; Sykes SM; Silva AC; D'Andrea AD; Hua X
Cancer Res; 2003 Jul; 63(14):4204-10. PubMed ID: 12874027
[TBL] [Abstract][Full Text] [Related]
20. Menin missense mutants associated with multiple endocrine neoplasia type 1 are rapidly degraded via the ubiquitin-proteasome pathway.
Yaguchi H; Ohkura N; Takahashi M; Nagamura Y; Kitabayashi I; Tsukada T
Mol Cell Biol; 2004 Aug; 24(15):6569-80. PubMed ID: 15254225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
